GenScript

GenScript Biotech Corporation (HK.1548) is an important technology and service provider in the world for life science R&D and manufacture. Built upon its solid DNA synthesis technology, GenScript Biotech comprises four major business units: a life-science services and products business unit, a biologics contract development and manufacturing organization (CDMO) business unit, an industrial synthetic products business unit, and an integrated global cell therapy company.

GenScript Biotech was founded in New Jersey, USA in 2002 and listed on the Hong Kong Stock Exchange in 2015. The company’s business operations span over 100 countries and regions worldwide with legal entities located in the U.S., China, Japan, Singapore, Netherlands, Ireland, the United Kingdom, Korea, Belgium and Spain. GenScript Biotech provides premium, convenient and reliable services and products for over 200,000 customers.

As of June 30, 2024, GenScript Biotech had more than 6,900 employees globally, and 103,600 peer-reviewed journal articles worldwide had cited GenScript Biotech’s services and products. In addition, GenScript Biotech owns a number of intellectual property rights, including over 300 patents, over 900 patent applications and great numbers of know-how secrets.

Driven by the corporate mission of “make people and nature healthier through biotechnology”, GenScript Biotech strives to become the most trustworthy biotech company in the world.

AWARDS
  • 2023 Best Places to Work
  • 2024 Best Places to Work
  • Genscript citeab 2023.png
  • Genscript citeab 2020.png
  • Genscript citeab 2018.png
  • Genscript Best CDMO 2021.jpg
860 Centennial Ave.
Piscataway, NJ 08854
  • Featured Employer
HIGHLIGHTS
The “GenTeer” platform is deeply rooted in GenScript’s corporate culture and core values, with a pragmatic approach that aligns with the ESG (Environmental, Social, and Governance) framework.
This flagship offering addresses the urgent demand for delivering gene constructs with unmatched speed, quality, and cost-efficiency.
Strong Revenue Growth and Strategic Advances Across Key Segments, Enhances Commitment to ESG and Sustainable Development
Employee Testimonials
  • I love that GenScript has a partnership with Wharton Online to provide Ivy League courses that we can take to further our professional development and personal growth. You can take online courses at your own pace on everything from effective communication methods to coping with stress. You can use them as credits for various certifications as well.
    Arielle Karp, Regional Sales Manager
  • The best part of working at GenScript is the opportunity to learn and grow. We are a team and everyone works to build each other up for the benefit of the team and, in turn, the individual. It has been great to surround myself with people who know so much and want to pass it on to you.
    Jason Meyer, Sr Technical Account Manager
  • GenScript is very fast paced and people adopt new ideas very quickly. Colleagues are friendly, humble to learn more and welcome suggestions. The company is generous to its employees. I see improvement every day!
    Cedric Wu, VP Innovation Center
NEWS
This week’s news ranged from BioSpace’s on-the-ground updates from DIA to safety concerns in clinical trials to BIOSECURE Act updates to new projections that the GLP-1 market could top $100 billion within 10 years.
The House Select Committee asks the FBI for a briefing on GenScript’s links to China, fueling the challenge facing public relations and investor relations teams at US biopharma firms and Chinese CDMOs.
The most recent figure for the China coronavirus outbreak is 28,018 confirmed cases with 563 deaths in China. Chinese health authorities indicate 19 foreigners have been infected by the virus. There are reports that a Chinese newborn is the youngest person to become infected. The infant was diagnosed 30 hours after birth, apparently having gotten it from the mother.
JOBS
IN THE PRESS